Media Room
Fourth Quarter and Full Year 2024 Results
Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.
Thursday January 30, 2025
15:00 - 16:30 CET (9:00am – 10:30am EST)
Press releases
February 25, 2025
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
February 22, 2025
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
February 19, 2025
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Sustainability Statement 2024 (ESG Report)
XBRL Viewer URD 2024
Registration Document 2024 (in French)
XBRL Viewer 20F 2024